Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 110451-110500 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03421639
Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis
PHASE4
Active, not recruiting
300 participants
Started: Dec 1, 2017 · Completed: Sep 30, 2024
3 conditions
1 sponsor
3 locations
NCT03358472
Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
PHASE3
Active, not recruiting
89 participants
Started: Dec 1, 2017 · Completed: Dec 19, 2025
1 condition
2 sponsors
73 locations
NCT03347162
Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer
N/A
Active, not recruiting
1,000 participants
Started: Dec 1, 2017 · Completed: Dec 31, 2026
6 conditions
1 sponsor
1 location
NCT06044038
Exercise Intervention for People With Schizophrenia (CREW)
NA
Recruiting
100 participants
Started: Dec 1, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03391843
Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer
PHASE2
Active, not recruiting
100 participants
Started: Dec 1, 2017 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03213093
Pressure and Diabetic Foot
NA
Recruiting
200 participants
Started: Dec 1, 2017 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT03399110
XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)
PHASE3
Active, not recruiting
1,032 participants
Started: Dec 1, 2017 · Completed: Aug 1, 2026
1 condition
1 sponsor
9 locations
NCT03699228
China Health Big Data
N/A
Recruiting
30,000 participants
Started: Dec 1, 2017 · Completed: Dec 31, 2026
3 conditions
15 sponsors
6 locations
NCT03375619
Long-term Follow-up Study of Patients Receiving CAR-T Cells
N/A
Recruiting
500 participants
Started: Dec 1, 2017 · Completed: Jan 1, 2035
9 conditions
1 sponsor
1 location
NCT06545448
Appropriateness of Angioplasty in Patients With Chronic Coronary Syndromes
N/A
Recruiting
1,875 participants
Started: Dec 1, 2017 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT03368677
Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression
N/A
Active, not recruiting
26 participants
Started: Dec 1, 2017 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03870230
Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects
NA
Recruiting
120 participants
Started: Dec 1, 2017 · Completed: Mar 31, 2026
3 conditions
1 sponsor
1 location
NCT03297125
Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI
N/A
Active, not recruiting
60 participants
Started: Dec 1, 2017 · Completed: Jan 1, 2026
1 condition
1 sponsor
1 location
NCT04319848
Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty
PHASE1
Recruiting
30 participants
Started: Dec 1, 2017 · Completed: Jun 30, 2028
4 conditions
1 sponsor
1 location
NCT03865914
Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy
N/A
Recruiting
2,000 participants
Started: Nov 30, 2017 · Completed: Dec 31, 2030
1 condition
15 sponsors
1 location
NCT03217110
Cerebellar Stimulation and Cognitive Control
NA
Recruiting
200 participants
Started: Nov 30, 2017 · Completed: Dec 1, 2025
5 conditions
1 sponsor
1 location
NCT03351062
Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
PHASE3
Recruiting
844 participants
Started: Nov 30, 2017 · Completed: Dec 31, 2025
1 condition
22 sponsors
21 locations
NCT03401047
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
EARLY_PHASE1
Recruiting
37 participants
Started: Nov 30, 2017 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT03077178
Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over
NA
Active, not recruiting
25 participants
Started: Nov 30, 2017 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT03345134
Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy
PHASE2
Not yet recruiting
20 participants
Started: Nov 30, 2017 · Completed: Jan 1, 2021
3 conditions
2 sponsors
1 location
NCT03136731
Evidence-based Screening Strategies for Celiac Disease
N/A
Enrolling by invitation
3,517 participants
Started: Nov 29, 2017 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT03286361
Clinical Trial Investigating the BeGraft Peripheral Plus Stent Graft System for Iliac Lesion Treatment
NA
Active, not recruiting
70 participants
Started: Nov 29, 2017 · Completed: Apr 30, 2025
1 condition
1 sponsor
9 locations
NCT03263572
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
PHASE2
Recruiting
90 participants
Started: Nov 29, 2017 · Completed: Nov 30, 2025
8 conditions
4 sponsors
1 location
NCT03379428
Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer
PHASE1/PHASE2
Active, not recruiting
34 participants
Started: Nov 29, 2017 · Completed: Jan 31, 2025
2 conditions
3 sponsors
1 location
NCT03180034
Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study
PHASE4
Active, not recruiting
27,945 participants
Started: Nov 29, 2017 · Completed: Aug 1, 2028
2 conditions
2 sponsors
1 location
NCT03398304
Defining the Temporal Changes in the Acute Phase Response During Graded Exercise: A Prospective Study
NA
Enrolling by invitation
35 participants
Started: Nov 29, 2017 · Completed: Apr 1, 2027
1 condition
1 sponsor
1 location
NCT03223753
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer
PHASE3
Active, not recruiting
300 participants
Started: Nov 29, 2017 · Completed: Mar 31, 2026
3 conditions
2 sponsors
118 locations
NCT03277638
Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
PHASE1/PHASE2
Recruiting
34 participants
Started: Nov 29, 2017 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04650984
A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma
PHASE3
Recruiting
102 participants
Started: Nov 29, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
28 locations
NCT05945082
Fusobacterium Nucleatum at Colorectal Cancer Sites
NA
Recruiting
150 participants
Started: Nov 29, 2017 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT02246270
Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)
PHASE1/PHASE2
Recruiting
30 participants
Started: Nov 28, 2017 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT03386500
Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer
PHASE1/PHASE2
Active, not recruiting
24 participants
Started: Nov 28, 2017 · Completed: Dec 31, 2029
2 conditions
2 sponsors
1 location
NCT03357536
Genetic Susceptibility to Listeriosis
NA
Recruiting
100 participants
Started: Nov 28, 2017 · Completed: Nov 30, 2027
1 condition
2 sponsors
1 location
NCT03364803
Collecting Information About Treatment Results for Patients With Cushing's Syndrome
N/A
Recruiting
300 participants
Started: Nov 28, 2017 · Completed: Nov 28, 2026
3 conditions
1 sponsor
7 locations
NCT04151277
PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer
PHASE2
Recruiting
500 participants
Started: Nov 28, 2017 · Completed: Jan 31, 2026
1 condition
3 sponsors
30 locations
NCT03386396
Brain Fuel - Morning Nutrition and Cognitive Function
NA
Active, not recruiting
151 participants
Started: Nov 28, 2017 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03432806
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
N/A
Active, not recruiting
51 participants
Started: Nov 28, 2017 · Completed: Nov 30, 2025
2 conditions
2 sponsors
4 locations
NCT03269474
Computational Drug Repurposing for All EBS Cases
N/A
Recruiting
60 participants
Started: Nov 28, 2017 · Completed: Dec 31, 2024
6 conditions
1 sponsor
1 location
NCT04161417
Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer
NA
Recruiting
2,500 participants
Started: Nov 28, 2017 · Completed: Dec 31, 2025
1 condition
3 sponsors
33 locations
NCT02812212
CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome
NA
Recruiting
75 participants
Started: Nov 28, 2017 · Completed: Apr 30, 2027
1 condition
1 sponsor
5 locations
NCT03307304
Investigations of Juvenile Neuronal Ceroid Lipofuscinosis
N/A
Recruiting
300 participants
Started: Nov 27, 2017 · Completed: Dec 31, 2050
2 conditions
1 sponsor
1 location
NCT03365882
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
PHASE2
Active, not recruiting
240 participants
Started: Nov 27, 2017 · Completed: Nov 30, 2025
19 conditions
2 sponsors
798 locations
NCT03252314
Ruptured Aneurysms Treated With Hydrogel Coils
N/A
Active, not recruiting
1,000 participants
Started: Nov 27, 2017 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03291028
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
N/A
Recruiting
16 participants
Started: Nov 27, 2017 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT03149029
Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma
PHASE2
Active, not recruiting
16 participants
Started: Nov 27, 2017 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT02994758
Development of Diagnostics and Treatment of Urological Cancers
NA
Recruiting
100 participants
Started: Nov 27, 2017 · Completed: Dec 31, 2025
5 conditions
2 sponsors
1 location
NCT02984410
"Study Assessing The Best of Radiotherapy vs the Best of Surgery in Patients With Oropharyngeal Carcinoma"
NA
Active, not recruiting
112 participants
Started: Nov 27, 2017 · Completed: Jun 30, 2029
3 conditions
1 sponsor
32 locations
NCT03267433
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
PHASE3
Active, not recruiting
689 participants
Started: Nov 27, 2017 · Completed: Jan 31, 2027
1 condition
2 sponsors
375 locations
NCT03803423
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
NA
Recruiting
1,000 participants
Started: Nov 27, 2017 · Completed: Nov 27, 2025
2 conditions
6 sponsors
6 locations
NCT03331198
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
PHASE1/PHASE2
Recruiting
320 participants
Started: Nov 27, 2017 · Completed: Nov 26, 2027
2 conditions
1 sponsor
85 locations
Previous
1
More pages
2207
2208
2209
2210
2211
2212
2213
More pages
2369
Next